thymoquinone has been researched along with zinc oxide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghanem, HB | 1 |
| Banupriya, SK; Kavithaa, K; Poornima, A; Sumathi, S | 1 |
| A, P; B, SR; K, K; P, H; S, S; Sjs, B | 1 |
3 other study(ies) available for thymoquinone and zinc oxide
| Article | Year |
|---|---|
Impact of zinc oxide nanoparticles and thymoquinone in Ehrlich ascites carcinoma induced in mice.
Topics: Animals; Benzoquinones; Carcinoma, Ehrlich Tumor; Female; Gene Expression Regulation, Neoplastic; Mice; Nanoparticles; Neoplasm Proteins; Zinc Oxide | 2021 |
Mechanistic Study on Thymoquinone Conjugated ZnO Nanoparticles Mediated Cytotoxicity and Anticancer Activity in Triple-Negative Breast Cancer Cells.
Topics: Antineoplastic Agents; Apoptosis; Benzoquinones; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Nanoparticles; Reactive Oxygen Species; Structure-Activity Relationship; Zinc Oxide | 2022 |
Modulation of gene expression by thymoquinone conjugated zinc oxide nanoparticles arrested cell cycle, DNA damage and increased apoptosis in triple negative breast cancer cell line MDA-MB-231.
Topics: Apoptosis; Benzoquinones; Cell Cycle; Cell Line, Tumor; DNA Damage; Gene Expression; Humans; Triple Negative Breast Neoplasms; Zinc Oxide | 2021 |